| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |